New Awards from RFA-DK-23-007: HIRN Consortium on Beta Cell Death and Survival (CBDS)

Six new awards were announced for the newly created HIRN Consortium on Beta Cell Death and Survival (CBDS) (RFA-DK-23-007):

• Decoding the Cell-specific Impact of Epigenomic and Alternative Splicing Regulation during T1D Progression (U01 DK143498)
  Shuibing Chen*, PhD, Weill Cornel Medical Medicine
  Stephen Parker, PhD, University of Michigan

• The Role of Granular Acidification in the Pathogenesis of Type 1 Diabetes (U01 DK143495)
  Thomas Delong*, PhD, University of Colorado Anschutz

• Interferon Signaling in the T1D Islet Microenvironment (U01 DK127786)
  Raghu G Mirmira*, MD, PhD, University of Chicago
  Carmella Evans-Molina, MD, PhD, Indiana University School of Medicine
  Ernesto Satoshi Nakayasu, PhD, Pacific Northwest National Laboratory

• Driving next generation UPR inhibitory kinase inhibitors for T1D (U01 DK143500) 
  Feroz Papa*, MD, PhD, University of California, San Francisco
  Dustin Maly, PhD, University of Washington

• Role of Pancreatic Elastase in Beta Cell Health, Autoimmunity and Type 1 Diabetes (U01 DK143494)
  Scott Oakes*, MD, University of Chicago
  Rohit Kulkarni, MD, PHD, Joslin Diabetes Center
  Mark Anderson, MD, PhD, University of California, San Francisco

• Beta Cell Death in Early Type 1 Diabetes Caused by Innate Immune Response to Inefficient RNA Editing (U01 DK143477)
  Klaus Kaestner*, PhD, University of Pennsylvania

* Denotes Contact PI